Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | GPR3 | P46089 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16623822 | 0.93 | JAK2 (0.33) | CYP1A2GPR3CYP2D6JAK2ALDH1A1 | |
| SCHEMBL16623829 | 0.89 | CYP1A2 (0.36) | CYP1A2CYP2D6CYP19A1 | |
| SCHEMBL16623727 | 0.89 | CYP1A2 (0.38) | CYP1A2CYP2D6ALDH1A1POLBCYP19A1 | |
| SCHEMBL16623746 | 0.87 | CYP1A2 (0.31) | CYP1A2CYP2D6ALDH1A1GAAKDM4E | |
| SCHEMBL16623735 | 0.87 | GPR3 (0.34) | CYP1A2GPR3CYP2D6JAK2ALDH1A1 | |
| SCHEMBL16623817 | 0.87 | CYP1A2 (0.31) | CYP1A2CYP2D6 | |
| SCHEMBL16623835 | 0.86 | — | — | |
| SCHEMBL16623839 | 0.82 | CYP1A2 (0.30) | CYP1A2CYP2D6 | |
| SCHEMBL16623749 | 0.80 | PTPN1 (0.36) | ALDH1A1KDM4E | |
| SCHEMBL16623731 | 0.80 | CYP1A2 (0.33) | CYP1A2GPR3CYP2D6JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180047913-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | JNC CORPORATION (JP) | 2018-02-15 | — | — | US | disclosed |
| US-9741950-B2 | Polycyclic aromatic compound | KYOTO UNIVERSITY (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160049600-A1 | POLYCYCLIC AROMATIC COMPOUND | SK MATERIALS JNC CO., LTD. (KR) | 2016-02-18 | — | — | US | disclosed |
| US-9166176-B2 | Polycyclic aromatic compound | KYOTO UNIVERSITY (JP) | 2015-10-20 | — | — | US | disclosed |
| US-20150097162-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | JNC CORPORATION (JP) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180047913-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | L1CAM, VDAC1, VDAC2 | CYP1A2 2204/4885GPR3 3119/4885CYP2D6 3674/4885 |
| US-20160049600-A1 | POLYCYCLIC AROMATIC COMPOUND | BICRA, PAH, SMARCC2 | CYP1A2 483/4885GPR3 3267/4885CYP2D6 1048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.